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a protocol of using the technique for established cases 
of endocarditis, in which the incidence of prosthetic 
valve endocarditis highest. 
It is logical to consider the concept of impregnating 
all valves with antibiotics to minimize prosthetic valve 
endocarditis caused by perioperative contamination. 
We suggest hat to minimize crossclamp time but to 
provide adequate short-term local antibiotic levels in 
the valve sewing ring, a commercially available valve 
with a protein-sealed sewing ring could be soaked with 
rifampicin, similar to established techniques used in 
vascular surgery. 2'3 
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Measurement of aortic diameter 
To the Editor." 
In the October 1996 issue of the Journal, Weinert and 
colleagues 1 give an elegant account of their measurements 
of aortic diameter by means of multiplane transesopha- 
geal echoeardiography. I have no complaints whatsoever 
concerning the excellence of the techniques described, but 
I have major problems with the anatomic structures that 
are purported to be measured. Apart from the fact that 
there is no ringlike structure 2' 3 supporting the hinge- 
points of the aortic valve leaflets (the so-called "anulus"), 
if the Chicago group makes measurements as they claim, 
then it is impossible for them to quantify the fullest 
diameter of the aortic root. The reason, of course, is that 
the aortic valve possesses three sinuses and leaflets and, 
even though the sinuses are rarely completely equal, 4
measuring from the basal attachment of the noncoronary 
leaflet o the basal attachment of the right coronary leaflet 
will always produce a chord of the outflow tract. Calcula- 
tions on the basis of the aortic root being a circle shows 
that measurements of the kind proposed underestimate 
the true diameter by a factor of 10% or more. The aortic 
root, of course, is not a true circle, but these geometric 
considerations are surely worthy of at least some discus- 
sion in studies of this kind. 
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Neuropsychologic outcome after normothermic 
cardiopulmonary bypass 
To the Editor: 
We agree happily with virtually all of Professor Trea- 
sure's commentary following our paper. 1 Indeed, our 
agreement is already explicit in the text. We planned and 
executed a randomized controlled study within pre-recog- 
nized externally applied constraints on numbers. We 
considered the available outcome measures and con- 
cluded that none would provide sufficient power to detect 
differences of any interesting size with the numbers avail- 
able. We welcome the consensus ofexperts that has taken 
place since our study was planned and completed, but 
know that the consensus i as much a way of sharing 
responsibility for error as a guaranteed pathway to truth. 
With the information available at the time, we made a 
prospective choice of an outcome measure that should 
logically have been more sensitive than existing ones and 
declared it to be our primary measure. No pilot data were 
available on this measure that could have informed pro- 
spective power calculations. It proved, in any case, to have 
enough power to detect an interesting difference with 95% 
confidence, although we made no secret of our doubt as to 
the clinical meaning of the difference. We identified the 
further analysis as being subsidiary, to inform further 
studies on the problems of this nature. 
Nowhere did we use our results to draw inferences 
about stroke rate. Nowhere did we draw any conclusions 
about safety. Our concluding sentence remarked that our 
results, and the absence of any separate demonstration f 
benefit, provided little incentive to recommend the rou- 
tine use of normothermic systemic perfusion (instead of 
